NCT00353912View on ClinicalTrials.gov

Efficacy & Safety of Orally Administered Valsartan/Amlodipine Combo Therapy vs Amlodipine Monotherapy in Black Patients With Stage II Hypertension

PHASE3CompletedINTERVENTIONAL
Enrollment

571

Participants

Timeline

Start Date

June 30, 2006

Primary Completion Date

April 30, 2007

Study Completion Date

April 30, 2007

Conditions
Hypertension
Interventions
DRUG

valsartan + amlodipine

Trial Locations (1)

07936

Novartis Pharmaceuticals, East Hanover

Sponsors

Lead Sponsor

Novartis
All Listed Sponsors
lead

Novartis

INDUSTRY